Good late homograft function was the rule, with all the survivors being free of reoperation for valve failure. At a mean follow-up of 42 +/- 28 months, 41 patients (87% of the survivors ...
[which] appears to refute positive reports about homograft use,” warns Stephen Westaby (Oxford Heart Centre, UK). Further studies to validate these results may also elucidate valve degeneration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results